Harpoon Therapeutics Statistics Share Statistics Harpoon Therapeutics has 37.6M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 37.6M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 25.56M Failed to Deliver (FTD) Shares 18,666 FTD / Avg. Volume 1.65%
Short Selling Information The latest short interest is 538.39K, so 0% of the outstanding
shares have been sold short.
Short Interest 538.39K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.36 and the forward
PE ratio is null.
Harpoon Therapeutics's PEG ratio is
0.01.
PE Ratio -0.36 Forward PE n/a PS Ratio 0.75 Forward PS n/a PB Ratio 4.46 P/FCF Ratio -0.27 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Harpoon Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.04,
with a Debt / Equity ratio of 2.96.
Current Ratio 1.04 Quick Ratio 1.04 Debt / Equity 2.96 Debt / EBITDA -0.24 Debt / FCF -0.18 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $709.22K Profits Per Employee $-1.49M Employee Count 45 Asset Turnover 0.43 Inventory Turnover n/a
Taxes Income Tax -594K Effective Tax Rate 0.88%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.55, so Harpoon Therapeutics's
price volatility has been higher than the market average.
Beta 1.55 52-Week Price Change n/a 50-Day Moving Average 21.18 200-Day Moving Average 10.91 Relative Strength Index (RSI) 82.72 Average Volume (20 Days) 1,129,503
Income Statement In the last 12 months, Harpoon Therapeutics had revenue of 31.91M
and earned -67.14M
in profits. Earnings per share was -20.24.
Revenue 31.91M Gross Profit 28.82M Operating Income -68.33M Net Income -67.14M EBITDA -65.97M EBIT -68.33M Earnings Per Share (EPS) -20.24
Full Income Statement Balance Sheet The company has 51.61M in cash and 16.01M in
debt, giving a net cash position of 35.61M.
Cash & Cash Equivalents 51.61M Total Debt 16.01M Net Cash 35.61M Retained Earnings -352.52M Total Assets 47.58M Working Capital 16.19M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -89.18M
and capital expenditures -347K, giving a free cash flow of -89.53M.
Operating Cash Flow -89.18M Capital Expenditures -347K Free Cash Flow -89.53M FCF Per Share -26.99
Full Cash Flow Statement Margins Gross margin is 90.3%, with operating and profit margins of -214.08% and -210.36%.
Gross Margin 90.3% Operating Margin -214.08% Pretax Margin -212.22% Profit Margin -210.36% EBITDA Margin -206.7% EBIT Margin -214.08% FCF Margin -280.52%
Dividends & Yields HARP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for HARP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 5, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Sep 5, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 0.58 Piotroski F-Score 2
